Navigation Links
Delaware Chancery Court Grants Galil Medical Ltd.'s Motion for Expedited Proceeding in Suit Against Endocare
Date:6/16/2009

YOKNEAM, Israel and PLYMOUTH MEETING, Pa., June 16 /PRNewswire/ -- On June 15, 2009, the Honorable William B. Chandler III, Chancellor for the State of Delaware, granted Galil Medical Ltd.'s motion for an expedited trial in Galil's recently-filed lawsuit against Endocare, Inc., arising out of Endocare's alleged breach of the Galil/Endocare Merger Agreement. The Chancellor granted Galil's motion after oral argument, and ordered that a two-day trial would be held on July 9 and 10 in Chancery Court in Georgetown, Delaware. Chancellor Chandler further indicated that he expected to issue a judgment in the suit by July 13, 2009, the Monday following the conclusion of the scheduled trial. Under the expedited schedule, Endocare is required to submit its answer to Galil's Complaint by June 19. Moreover, the previous termination date for the Galil/Endocare Merger Agreement (June 30) now has been extended so that Galil and Endocare will have additional time to complete their planned merger once the Chancellor rules.

Galil, a global cryotherapy company, filed the suit on June 9, 2009, to enforce the merger agreement between Galil and Endocare announced in November and to enjoin the proposed acquisition of Endocare by HealthTronics, Inc.

Martin J. Emerson, President and CEO of Galil, stated that Galil welcomed the Chancellor's decision to grant Galil's motion for an expedited trial. He stated that, "Galil remains committed to resolving this case as quickly as possible, and then concluding our merger with Endocare. The merger between Galil and Endocare remains in the best interests of both companies, as well as the interests of the doctors and patients we serve."

About Galil Medical

Galil Medical develops, manufactures and markets innovative products utilizing a proprietary cryotherapy platform that incorporates powerful freezing technology and revolutionary 17-gauge cryoablation needle design. Galil Medical's systems enable minimally invasive, targeted ablation of benign and cancerous tumors while ensuring rapid recovery and enhanced quality of life for patients. The Presice(TM) Cryoablation System features multi-point thermal sensors (MTS) and advanced IceVue(TM) planning software for excellent procedure control in treating prostate and renal cancer. The SeedNet MRI(TM) system provides physicians with an easy-to-use cryoablation solution to precisely ablate tumors while protecting adjacent structures, under MRI guidance.

Galil Medical shareholders include Thomas, McNerney & Partners, The Vertical Group, Investor Growth Capital, Elron Electronic Industries Ltd. and RDC Rafael Development Corporation, Ltd. For more information, please visit www.galilmedical.com.


'/>"/>
SOURCE Galil Medical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Delaware Urologic Associate's, Dr. Peter J. Muench, Presents Advances in Incontinence Treatment with a New Perspective and Outlook
2. National Pharmacy Omnicare Pays 'Unusual' Settlement to Resolve Charges of Generic Drug Switching in Delaware Nursing Homes, Resulting From 'Qui Tam' Lawsuit
3. Growth in Delaware Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study
4. Universal Capital Management Reports Top Delaware Surgeon to Join Advisory Board
5. Delaware Youth Shares Epilepsy Message on Capitol Hill
6. Silverman, McDonald & Friedman Opens New Office in New Castle to Serve Legal Needs of Delaware Families
7. HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference
8. U.S. District Court in Delaware Reinstates Damage Awards to Cordis Corporation on Patents Infringed by Medtronic, Inc. and Boston Scientific Corporation
9. AARP Survey Reveals Boomers Health Care Needs in Delaware
10. AARP Represents the Pulse of Delawareans 50+: Survey Reveals Attitudes about Health Care in Delaware
11. PA Department of Health Urges Sexually Active Individuals in Delaware County to Get STD Tests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from PsychTests.com reveals that behind ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... ... ... Comfort Keepers® of San Diego, CA is excited to announce they are ... drive cancer patients to and from their cancer treatments. Comfort Keepers provides quality ... and ongoing independence. Getting to and from medical treatments is one of the ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... ALEXANDRIA, Va. , June 24, 2016 ... a set of recommendations that would allow ... information (HCEI) with entities that make formulary and coverage ... determine the "value" of new medicines. The ... that does not appear on the drug label, a ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
Breaking Medicine Technology: